PREDICTIVE VALUE OF APOLIPOPROTEIN-E GENOTYPING IN ALZHEIMERS-DISEASE - RESULTS OF AN AUTOPSY SERIES AND AN ANALYSIS OF SEVERAL COMBINED STUDIES

被引:124
作者
NALBANTOGLU, J
GILFIX, BM
BERTRAND, P
ROBITAILLE, Y
GAUTHIER, S
ROSENBLATT, DS
POIRIER, J
机构
[1] MCGILL STUDIES AGING, VERDUN H4H 1R3, PQ, CANADA
[2] MONTREAL NEUROL INST, MONTREAL, PQ, CANADA
[3] ROYAL VICTORIA HOSP, DIV CLIN BIOCHEM, MONTREAL, PQ, CANADA
[4] ROYAL VICTORIA HOSP, DIV MED GENET, MONTREAL, PQ, CANADA
[5] MCGILL UNIV, DOUGLAS HOSP, RES CTR, MONTREAL, PQ, CANADA
[6] UNIV MONTREAL, DEPT PATHOL, MONTREAL H3C 3J7, PQ, CANADA
关键词
D O I
10.1002/ana.410360614
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Apoliprotein E (apoE) is associated with Alzheimer's neurofibrillary tangles and beta-amyloid protein in senile plaques. Recent studies have shown an increased frequency of the epsilon 4 allele of the apoE gene in familial and sporadic cases of Alzheimer's disease (AD). In the present case control study, we have determined the apoE genotype by allele-specific extension of 113 postmortem cases of sporadic AD and 77 control brains shown to be free of AD neuropathological features and then calculated the frequency of the various allelic forms of apoE (epsilon 2, epsilon 3, epsilon 4). The odds ratio associating epsilon 4 with AD was 15.5 (95% confidence interval [CI] 6.2-38.5), and the population attributable risk was 0.53. We have also combined the results of our study and several others to calculate these same parameters in a larger population (570 controls and 961 AD subjects); the odds ratio for this larger group was 6.2 (95% CI 4.9-7.8) and the population attributable risk was 0.57. These results further substantiate and strengthen the association between the epsilon 4 allele of apoE gene and AD. We have also used these results to investigate the usefulness of the determination of epsilon 4 carrier status in the diagnosis of AD.
引用
收藏
页码:889 / 895
页数:7
相关论文
共 24 条
  • [1] ANWAR N, 1993, LANCET, V342, P1308, DOI 10.1016/0140-6736(93)92404-H
  • [2] COMPARATIVE ALTERATIONS OF NICOTINIC AND MUSCARINIC BINDING-SITES IN ALZHEIMERS AND PARKINSONS DISEASES
    AUBERT, I
    ARAUJO, DM
    CECYRE, D
    ROBITAILLE, Y
    GAUTHIER, S
    QUIRION, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) : 529 - 541
  • [3] PARKINSON DISEASE, DEMENTIA, AND ALZHEIMER-DISEASE - CLINICOPATHOLOGICAL CORRELATIONS
    BOLLER, F
    MIZUTANI, T
    ROESSMANN, U
    GAMBETTI, P
    [J]. ANNALS OF NEUROLOGY, 1980, 7 (04) : 329 - 335
  • [4] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [5] CZECH C, 1993, LANCET, V342, P1309
  • [6] AMINERGIC SYSTEMS IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE
    DAMATO, RJ
    ZWEIG, RM
    WHITEHOUSE, PJ
    WENK, GL
    SINGER, HS
    MAYEUX, R
    PRICE, DL
    SNYDER, SH
    [J]. ANNALS OF NEUROLOGY, 1987, 22 (02) : 229 - 236
  • [7] NEUROPATHOLOGIC AND CLINICAL-FEATURES OF PARKINSONS-DISEASE IN ALZHEIMERS-DISEASE PATIENTS
    DITTER, SM
    MIRRA, SS
    [J]. NEUROLOGY, 1987, 37 (05) : 754 - 760
  • [8] PURIFICATION OF DNA FROM FORMALDEHYDE FIXED AND PARAFFIN EMBEDDED HUMAN-TISSUE
    GOELZ, SE
    HAMILTON, SR
    VOGELSTEIN, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (01) : 118 - 126
  • [9] HILL JS, 1990, CLIN CHEM, V36, P1871
  • [10] DIAGNOSIS OF ALZHEIMERS-DISEASE
    KHACHATURIAN, ZS
    [J]. ARCHIVES OF NEUROLOGY, 1985, 42 (11) : 1097 - 1104